FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q58415785> ?p ?o ?g. }

• Q58415785 description "2017 թվականի ապրիլի 10-ին հրատարակված գիտական հոդված" @default.
• Q58415785 description "artículu científicu espublizáu n'abril de 2017" @default.
• Q58415785 description "im April 2017 veröffentlichter wissenschaftlicher Artikel" @default.
• Q58415785 description "scientific article published on 10 April 2017" @default.
• Q58415785 description "wetenschappelijk artikel" @default.
• Q58415785 description "наукова стаття, опублікована у квітні 2017" @default.
• Q58415785 name "A phase II Bayesian sequential clinical trial in advanced Waldenström macroglobulinemia patients treated with bortezomib: interest of addition of dexamethasone" @default.
• Q58415785 name "A phase II Bayesian sequential clinical trial in advanced Waldenström macroglobulinemia patients treated with bortezomib: interest of addition of dexamethasone" @default.
• Q58415785 type Item @default.
• Q58415785 label "A phase II Bayesian sequential clinical trial in advanced Waldenström macroglobulinemia patients treated with bortezomib: interest of addition of dexamethasone" @default.
• Q58415785 label "A phase II Bayesian sequential clinical trial in advanced Waldenström macroglobulinemia patients treated with bortezomib: interest of addition of dexamethasone" @default.
• Q58415785 prefLabel "A phase II Bayesian sequential clinical trial in advanced Waldenström macroglobulinemia patients treated with bortezomib: interest of addition of dexamethasone" @default.
• Q58415785 prefLabel "A phase II Bayesian sequential clinical trial in advanced Waldenström macroglobulinemia patients treated with bortezomib: interest of addition of dexamethasone" @default.
• Q58415785 P1433 Q58415785-3281526D-AD3C-4F9C-97C9-F81867D04E61 @default.
• Q58415785 P1476 Q58415785-CE3271D2-7F27-4479-B01A-D3E7507B1312 @default.
• Q58415785 P2093 Q58415785-23CFE8E9-7B19-495D-A5E2-D674A42E7213 @default.
• Q58415785 P2093 Q58415785-3BDBCFF8-37B0-4737-8874-5BE1FE25B17C @default.
• Q58415785 P2093 Q58415785-3E2A7169-C3EA-4A51-8CDA-89B0257B457C @default.
• Q58415785 P2093 Q58415785-4B361EC6-38FB-408F-B0E1-F439D95688A6 @default.
• Q58415785 P2093 Q58415785-4F34B101-5A15-4CBB-9291-F79AECD311C3 @default.
• Q58415785 P2093 Q58415785-4F7AF868-0B28-4353-BC53-55490863C893 @default.
• Q58415785 P2093 Q58415785-50A06C21-2388-47DE-BFEB-879075EFBF3C @default.
• Q58415785 P2093 Q58415785-6A1FDED7-1C75-4D6A-8779-DE2D57C89397 @default.
• Q58415785 P2093 Q58415785-7F5E8555-9A22-4D53-B131-5B7DD54E9F7C @default.
• Q58415785 P2093 Q58415785-8ADCFC24-C3F4-4E65-9A74-A18E9897A18E @default.
• Q58415785 P2093 Q58415785-9915FE84-1A71-4657-97B0-CB0F6646B3D8 @default.
• Q58415785 P2093 Q58415785-A01B3CA4-56E1-4789-AB2E-F0D7C40EF0F1 @default.
• Q58415785 P2093 Q58415785-A07F223F-7A61-4938-B9B7-69AB92ED45D4 @default.
• Q58415785 P2093 Q58415785-B2C701E0-6F15-49D6-A258-5A0FB7B9492A @default.
• Q58415785 P2093 Q58415785-BA42D0B8-9B97-417F-B008-046958ACF89B @default.
• Q58415785 P2093 Q58415785-C1DF6BDC-0693-447B-A5B9-BADD258872B0 @default.
• Q58415785 P2093 Q58415785-C596A196-DEC4-4362-BAA0-214E6419C92E @default.
• Q58415785 P2093 Q58415785-C7B2F2D2-04D4-4AE0-BA64-575C5F4DDD21 @default.
• Q58415785 P2093 Q58415785-F00FD279-4839-4C49-B5C9-27B150E75DBF @default.
• Q58415785 P2860 Q58415785-042627A9-2F35-4A5A-8F38-D575FBC4855E @default.
• Q58415785 P2860 Q58415785-0EA4E86A-1C78-471C-92C2-E89C194D9B6E @default.
• Q58415785 P2860 Q58415785-200C07B1-2D7B-4C10-9A85-1B7C55FC921A @default.
• Q58415785 P2860 Q58415785-3A1763E0-E182-4BE4-9D32-3249B97E6118 @default.
• Q58415785 P2860 Q58415785-458AF96A-F5FC-4BB0-9047-A66EDB5BF047 @default.
• Q58415785 P2860 Q58415785-465AF8C5-BF14-4C69-81EF-81CCD1BC74A0 @default.
• Q58415785 P2860 Q58415785-5283FB34-7B44-47BB-8CE6-05149BD68D13 @default.
• Q58415785 P2860 Q58415785-89496205-41DC-4FB4-B84D-DD343AA3CE22 @default.
• Q58415785 P2860 Q58415785-8DE233F1-DBA3-413D-9BD8-B80ABF14A4B9 @default.
• Q58415785 P2860 Q58415785-92155EB8-B87C-4118-8B97-E2564F48DC9E @default.
• Q58415785 P2860 Q58415785-935B78F6-699C-4667-91CB-5E54671DC7F2 @default.
• Q58415785 P2860 Q58415785-955776E5-D30D-4E96-AE96-9FBB9E3C2F57 @default.
• Q58415785 P2860 Q58415785-A5F24C71-11A4-4691-88E7-9378BEAC7FF2 @default.
• Q58415785 P2860 Q58415785-B1C85C7A-E119-4C7B-A076-1C0470B4F23C @default.
• Q58415785 P2860 Q58415785-B3E7B59B-35EB-48AD-A4EB-90A0D0ADFF6F @default.
• Q58415785 P2860 Q58415785-C09AB6FE-429C-407E-BFD7-9AAD1A888FA7 @default.
• Q58415785 P2860 Q58415785-C18F716F-BDFA-40E3-B708-0E52A33810DC @default.
• Q58415785 P2860 Q58415785-C29BA982-F1C7-4785-BF08-D47C26F1C446 @default.
• Q58415785 P2860 Q58415785-C841699B-4276-41D6-936B-1CC73F9EC0E6 @default.
• Q58415785 P2860 Q58415785-D2009766-C02B-44D4-BE26-AE348AC3518D @default.
• Q58415785 P2860 Q58415785-D96D8081-C115-4B4E-BB80-4E22D70F0708 @default.
• Q58415785 P2860 Q58415785-F77D2356-131B-44D4-A880-6BA6B4722DC7 @default.
• Q58415785 P304 Q58415785-479C6C4F-3DDC-4655-9062-E166778152C7 @default.
• Q58415785 P31 Q58415785-F04582F4-B5A3-4AAE-AE58-1128623281E7 @default.
• Q58415785 P356 Q58415785-C55C39D0-6610-4BD2-9493-73F082D47BD5 @default.
• Q58415785 P433 Q58415785-E6F781C6-8028-4DD8-950D-7E3E517964ED @default.
• Q58415785 P478 Q58415785-DA622C3F-0DCF-40AE-9F78-5EDCD5B1FBBA @default.
• Q58415785 P50 Q58415785-4D7EAC81-46E2-483C-A15F-708EAD3DD19E @default.
• Q58415785 P50 Q58415785-5B6BFDED-B5F0-4D63-A24E-8FC96864E7C7 @default.
• Q58415785 P577 Q58415785-DB3D2D5D-05C2-4CC0-B4CC-9CFA64F2ECD5 @default.
• Q58415785 P698 Q58415785-64647ECE-6418-42FE-9FC7-084FF469363C @default.
• Q58415785 P921 Q58415785-4F5E5FEE-557F-404D-904D-FBFBC29B94C8 @default.
• Q58415785 P921 Q58415785-624A8115-29A8-41E3-BBAD-0EC669722624 @default.
• Q58415785 P356 10428194.2017.1307357 @default.
• Q58415785 P698 28395585 @default.
• Q58415785 P1433 Q6534493 @default.
• Q58415785 P1476 "A phase II Bayesian sequential clinical trial in advanced Waldenström macroglobulinemia patients treated with bortezomib: interest of addition of dexamethasone" @default.
• Q58415785 P2093 "Anne Banos" @default.
• Q58415785 P2093 "Anne Vekhoff" @default.
• Q58415785 P2093 "Brigitte Dreyfus" @default.
• Q58415785 P2093 "Brigitte Pégourié" @default.
• Q58415785 P2093 "Bruno Anglaret" @default.
• Q58415785 P2093 "Béatrice Mahé" @default.
• Q58415785 P2093 "Carole Soussain" @default.
• Q58415785 P2093 "Caroline Dartigeas" @default.
• Q58415785 P2093 "French Innovative Leukemia Organization (FILO)" @default.
• Q58415785 P2093 "Hervé Oya" @default.
• Q58415785 P2093 "Julie Lejeune" @default.
• Q58415785 P2093 "Marie-Sarah Dilhuidy" @default.
• Q58415785 P2093 "Maya Ouzegdouh" @default.
• Q58415785 P2093 "Olivier Tournilhac" @default.
• Q58415785 P2093 "Pierre Morel" @default.
• Q58415785 P2093 "Stéphane Leprête" @default.
• Q58415785 P2093 "Thérèse Aurran" @default.
• Q58415785 P2093 "Véronique Leblond" @default.
• Q58415785 P2093 "Xavier Leleu" @default.
• Q58415785 P2860 Q27853148 @default.
• Q58415785 P2860 Q33374513 @default.
• Q58415785 P2860 Q33375461 @default.
• Q58415785 P2860 Q33388196 @default.
• Q58415785 P2860 Q33390926 @default.
• Q58415785 P2860 Q33394873 @default.
• Q58415785 P2860 Q34608608 @default.
• Q58415785 P2860 Q36461011 @default.
• Q58415785 P2860 Q36764811 @default.
• Q58415785 P2860 Q37725456 @default.

• next